In Victory For Device Industry, Supreme Court Favors PMA Pre-emption
This article was originally published in The Gray Sheet
Executive Summary
In a ruling that is expected to shave the volume of lawsuits against device manufacturers, the Supreme Court held that FDA premarket approval should preclude patients from suing companies for personal injury in most cases